跳至主要内容
临床试验/CTRI/2025/09/094223
CTRI/2025/09/094223尚未招募4 期

Efficacy of Ondansetron with and without venous occlusion in the reduction of Propofol injection pain, A Double Blind Randomized Controlled Trial

All India Institute of Medical Sciences Gorakhpur1 个研究点 分布在 1 个国家目标入组 174 人开始时间: 2025年10月15日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
174
试验地点
1
主要终点
Incidence of propofol injection pain in the three study groups.

研究概览

简要总结

This double-blind randomized controlled trial aims to evaluate the efficacy of ondansetron pretreatment with and without venous occlusion in preventing propofol injection pain. A total of 174 adult patients undergoing elective surgery at AIIMS Gorakhpur will be enrolled. After standard monitoring and pre-oxygenation, patients will receive the allocated intervention, followed by a standardized propofol infusion. Pain at the injection site will be assessed using the Verbal Numerical Rating Scale. The primary outcome is the incidence of propofol injection pain, while secondary outcomes include pain severity, postoperative nausea and vomiting, and any adverse effects.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant, Investigator, Outcome Assessor and Date-entry Operator Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients aged
  • 60 years old, of either sex, physical status (ASA) I and II, who are scheduled for elective surgery under general anaesthesia with propofol induction with 20-gauge IV cannula at the dorsum of hand prior to surgery.

排除标准

  • Patient refusal, Patients allergic to ondansetron, lignocaine or propofol,Patients who did not receive propofol for induction,Patients who used apomorphine, dronedarone, monoamine oxidase inhibitors and serotonergic drugs, Patients with cardiac arrhythmia like prolonged QT Syndrome or 2nd/3rd degree AV Block, Patients who had chronic pain , Patients who did not have 20G IV Cannula on the dorsum of the hand, Patients who received rapid sequence intubation technique.

结局指标

主要结局

Incidence of propofol injection pain in the three study groups.

时间窗: At the time of giving injection

次要结局

  • Severity of propofol injection pain in the three study groups.(till post operative 2 hours)
  • Incidence of postoperative nausea & vomiting in the three study groups,(till post operative 2 hours)
  • Incidence of adverse effects, if any.(till post operative 2 hours)

研究者

发起方
All India Institute of Medical Sciences Gorakhpur
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Priyanka Dwivedi

AIIMS Gorakhpur

研究点 (1)

Loading locations...

相似试验